BioCentury
ARTICLE | Clinical News

Xechem preclinical data

March 1, 2004 8:00 AM UTC

XKEM subsidiary CepTor Corp. (Stony Brook, N.Y.) reported that Neurodur reduced clinical signs and increased survival in a mouse model of MS. XKEM said it would file an IND for Neurodur to treat MS b...